CD19 and B-cell chronic lymphocytic leukemia: Of the 14 patients who received thawed SB CD19-specific CAR T-cells (viability, mean ± SD, 98.8% ± 2.13%, Supplementary Table S1), 8 patients had B-ALL, 4 patients had DLBCL and 2 patients had CLL.